Home-based Gait and Balance Training in Patients with Movement Disorders
Launched by FORSCHUNGSZENTRUM JUELICH · Sep 20, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with movement disorders, like ataxia or Parkinson's disease, improve their walking and balance. Participants will take part in a three-week training program that involves personalized exercises they can do at home, guided by videos. There are two training schedules: one involves 20 minutes of training four times a week, while the other consists of 40 minutes of training just two times a week. Before starting the training, everyone will have a week to get familiar with the study procedures, and then they'll be randomly assigned to one of the training groups or a control group where they won’t receive any additional training during the study.
To join this trial, participants must be diagnosed with cerebellar ataxia or Parkinson's disease and should be able to walk unaided for at least four meters at home. Unfortunately, those with other serious health issues, a history of frequent falls, or those who can't give consent will not be eligible. Participants can expect to receive personalized training designed to help them improve their movement skills, and those in the control group will have the chance to access the training after the study is completed. This research aims to find out the best way to help improve balance and walking in patients with these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • clinical diagnosis of cerebellar ataxia or idiopathic Parkinson's syndrome
- • opportunity to walk a distance of four meters unhindered at home
- Exclusion Criteria:
- • other diseases with an impact on motor skills
- • severe primary psychiatric illnesses
- • current drug or alcohol addiction
- • consumptive diseases
- • poor general condition
- • increased risk of falling (anamnestic fall frequency of ≥ 1x per week or as assessed by the attending physician)
- • incapacitated patients in official or court custody or patients unable to give consent
- • for PD patients taking medication: not being able to carry out the measurement in the on-phase of the medication
About Forschungszentrum Juelich
Forschungszentrum Jülich is a leading interdisciplinary research center in Germany, dedicated to advancing scientific knowledge and innovation across various fields, including health, energy, and environment. As a prominent sponsor of clinical trials, it leverages state-of-the-art facilities and a collaborative approach to foster groundbreaking research and development in biomedicine. With a commitment to translating scientific discoveries into practical applications, Forschungszentrum Jülich engages in strategic partnerships with academic institutions, industry, and healthcare organizations, aiming to enhance patient care and contribute to the global understanding of complex health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Düsseldorf, Nrw, Germany
Patients applied
Trial Officials
Martina Minnerop, PD Dr. med.
Principal Investigator
Institut für Neurowissenschaften und Medizin (INM-1), Forschungszentrum Jülich GmbH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported